Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Etanercept effectively treated a severe skin condition when other treatments failed.

ZD1839 can cause skin issues like acne and hair changes.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

Effective immunomodulatory treatments and a personalized approach are crucial for managing severe folliculitis decalvans.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.